6 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 2, 4 Phase 3, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Active not recruiting 1 |
| Phase 3 | 4 | Completed 4 |
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
Follow meplazumab: new trials by email Literature Review of meplazumab trials Research Report on meplazumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum Meplazumab for Injection - Malaria | Phase 2 | Active not recruiting | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 60 | 2024-04-26 | 2024-10-29 |
| Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19 Meplazumab for injection, Normal saline - COVID-19 | Phase 3 | Completed | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 108 | 2024-01-19 | 2024-05-28 |
| To Evaluate the Safety and Efficacy of Meplazumab in Treatment of Post-COVID-19 Meplazumab for injection, Normal saline - Post-COVID-19 | Phase 3 | Completed | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 121 | 2023-03-23 | 2024-05-28 |
| Clinical Study of Meplazumab to Treat With Malaria Meplazumab for Injection, Sterile normal saline (0.9%) - Malaria (Plasmodium Falciparum) | Phase 1 | Withdrawn | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 2023-03-01 | 2023-09-21 | |
| the Safety and Efficacy of Meplazumab in Patients With COVID-19 Meplazumab for Injection, Sterile normal saline (0.9%) - Covid19 | Phase 2 / Phase 3 | Completed | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 150 | 2022-01-21 | 2023-09-15 |
| Study to Assess the Effect of Meplazumab on COVID-19 Meplazumab for Injection, Sterile normal saline (0.9%) - COVID-19 | Phase 2 / Phase 3 | Completed | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | 174 | 2021-02-15 | 2023-09-15 |
| A Phase I Clinical Trial of Meplazumab in Healthy Volunteer meplazumab for injection, Placebo - Healthy Volunteers | Phase 1 | Completed | Xijing Hospital | 59 | 2020-04-25 | 2021-04-09 |
| Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia Meplazumab for Injection - Coronavirus Disease 2019 (COVID-19) | Phase 1 / Phase 2 | Completed | Tang-Du Hospital | 17 | 2020-02-03 | 2021-04-09 |
COVID-19 (4) · Malaria (1) · Malaria, Falciparum (1) · Pneumonia (1)
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd (6) · Tang-Du Hospital (1) · Xijing Hospital (1)
China (5) · Brazil (1) · Kenya (1)
Hongzhou Lu (1) · Yingxia Liu (1) · Yinzhong Shen (1)